Smoking Cessation Invention in the Emergency Department (ED)
NCT ID: NCT01173653
Last Updated: 2012-12-27
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
199 participants
INTERVENTIONAL
2010-07-31
2011-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Our study is novel in that it introduces a brief smoking intervention through use of an established, federally-funded and federally-sponsored cessation counseling resource, the National Smoking Cessation Quit Line, also available at smokefree.gov. This is a joint initiative between the Tobacco Control Research Branch of the National Cancer Institute and the Centers for Disease Control and Prevention. Since ED patients who smoke often lack the ability to use self-help cessation resources, we hypothesize that by introducing this population to the counselors on the National Smoking Cessation Quit Line (also called the 1-800-QUIT-NOW line) during the ED visit via phone, that this new brief intervention would have a realizable and significant effect on smoking cessation among the this population.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Given this background, our research proposal has the following specific aims:
1. The ED is an effective location within the domestic health system to provide preventive medical care, including counseling on smoking cessation.
2. A simple intervention where ED patients who were motivated to quit smoking were put in direct phone contact with a trained smoking cessation counselor, during their ED stay, will have a realizable benefit in rates of smoking cessation beyond the placebo rate of cessation.
3. We hypothesize that smokers who are motivated to quit will react positively to the national quit line and will have a higher rate of cessation at two months time compared to other motivated smokers in the ED department who are not put in immediate contact with a smoking cessation counselor.
A background statistical analysis and literature review has already been conducted. A literature review has been attached for reference (see Appendix A). We have discussed this topic with our biostatistical liaison and we believe such a study can show statistical significance with appropriate power based on a target enrollment of 150 patients.
Following anticipated IRB approval, we expect this study to be ready for enrollment. Mr. Pelster will be the lead enrollee within the Adult Emergency Department and has the full support of the ED faculty and staff for this work. He will be supervised directly by Dr. Benjamin Heavrin, Assistant Professor of Emergency Medicine, who will function as his faculty sponsor through the VUSM emphasis program. All patients presenting to the Adult Emergency Department are asked about smoking status through the triage note. Mr. Pelster will have access to this triage note and will approach patients who meet inclusion criteria. Our inclusion criteria includes: verbally consenting patients of the Adult ED who actively smoke, have normal vital signs, and are not emergency will based on triage criteria. Exclusion criteria includes patients unable to provide consent, unable to verbally communicate, patients with emergent illness defined by ESI triage protocols, patients with unstable vitals, and patients under the age of 18. Mr. Pelster will then approach these patients for possible enrollment. Prior to the beginning of this study, Mr. Pelster will become well read on current smoking statistics and on the medical and health related benefits of smoking cessation, should patient questions arise. He will be supervised in these verbal patient discussions by Dr. Heavrin.
All patients will be asked for voluntary, verbal informed consent. Should consent not be given, or should consent not be able to be obtained, a patient will not be included in this study. Given that no harm could come from this intervention in the ED, and given that the "intervention" is simply a verbal discussion on the motivation to quit smoking and a telephone conversation with a 1-800-QUIT-NOW professional, we believe that verbal consent would be acceptable. Patients who consent to the study will be given a letter that briefly explains the purpose of the clinical trial (see Appendix B).
Basic demographic data related to age, gender, race, smoking history, and contact information of the patient will be collected and stored on a secure electronic device as described below. Upon conclusion of enrollment, data analysis will begin using statistical software such as SPSS available through the Department of Emergency Medicine, Division of Research.
Although our investigative team does not have experience in smoking cessation research, plenty of evidence exists within the medical literature to suggest that studies on smoking cessation are simple in design, context, and data acquisition and that patients respond positively to preventive health interventions. Our investigative team will be working under the Division of Research, Department of Emergency Medicine, Vanderbilt University Medical Center. This department has plentiful resources to conduct this simple investigation, including biostatistical support, dedicated clinical trials associates, and a culture of rigorous and supportive academic investigation within the clinical wings of the department.
We expect no negative impact of this investigating on clinical care, the timeliness of care, or the disposition and treatment of the patients enrolled.
A literature search has been conducted and is included. Per our review, we do not believe that research into the utilization of the 1-800-QUIT-NOW line has occurred in an Adult ED population. Should our research prove our hypothesis, this would provide a simple intervention that would have large-scale positive public health ramifications for the ED smoking population.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard EM Smoking Cessation Info
Patients discharged from ER receive pamphlet re: smoking cessation
Smoking Cessation
Randomly introducing patients to a Department of Health program to help them quit smoking.
Patients contact 1-800-QUIT-NOW before leaving ED
Prior the patient leaving the ED, the PI will assist the patient with contacting 1-800-QUIT-NOW, who will help patient to quit smoking.
Smoking Cessation
A simple intervention where ED patients who were motivated to quit smoking were put in direct phone contact with a trained smoking cessation counselor during their ED stay.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Smoking Cessation
Randomly introducing patients to a Department of Health program to help them quit smoking.
Smoking Cessation
A simple intervention where ED patients who were motivated to quit smoking were put in direct phone contact with a trained smoking cessation counselor during their ED stay.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who are active smokers who present to the Adult ED at VUMC
* Patients who are able to give informed verbal consent
* Patients with stable vital signs
Exclusion Criteria
* Patients who are unable to communicate verbally as determined by the treating attending physician and/or triage nurse. This includes patients with alterations in mental status, who are cognitively impaired, or are intoxicated or on drugs
* Patients with abnormal vital signs, and triage ratings (ES1 score 1) suggesting immediate life threatening illness
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vanderbilt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ben Heavrin
Benjamin S. Heavrin, MD, MBA
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ben Heavrin, MD
Role: PRINCIPAL_INVESTIGATOR
Vanderbilt University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vanderbilt University Medical Center - Emergency Medicine
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
100411
Identifier Type: -
Identifier Source: org_study_id